organization · Reporting owner
LILLY ENDOWMENT INC
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
ELI LILLY & Co
Report date May 06, 2026 · Filed May 07, 2026
Section 16 reporting ended · disclosed 2026-05-07. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 91,881,150 |
Ending reported balance
After 2026-05-06 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-05-06 · Sale · Disposed 13,620 · Balance 91,883,358 F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $995.00 to $995.9963, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) and (2) to this Form 4. Row 2 · 2026-05-06 · Sale · Disposed 2,208 · Balance 91,881,150 F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $996.00 to $996.46, inclusive. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $995.00 to $995.9963, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) and (2) to this Form 4.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $996.00 to $996.46, inclusive.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 24, 2018 Filed Jul 25, 2018 15:47 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 62,765 | $92.90 | $5,830,617.44 |
DisclosureSEC source: 0001209191-18-043854 · doc4.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,545,936 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.3444 to $93.2798, inclusive. Read SEC document |
| July 24, 2018 Filed Jul 25, 2018 15:47 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 22,900 | $91.68 | $2,099,357.50 |
DisclosureSEC source: 0001209191-18-043854 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,608,701 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.331 to $92.2453, inclusive. Read SEC document |
| July 24, 2018 Filed Jul 25, 2018 15:47 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 69,203 | $90.76 | $6,280,656.67 |
DisclosureSEC source: 0001209191-18-043854 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,631,601 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.25 to $91.1614, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3) and (4) to this Form 4. Read SEC document |
| July 06, 2018 Filed Jul 9, 2018 14:45 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 180,000 | $87.44 | $15,738,300.00 |
DisclosureSEC source: 0001209191-18-041946 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,700,804 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.08 to $87.705, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| July 05, 2018 Filed Jul 6, 2018 15:13 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 170,000 | $86.62 | $14,725,740.00 |
DisclosureSEC source: 0001209191-18-041828 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,880,804 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $86.50 to $86.91, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| June 15, 2018 Filed Jun 18, 2018 16:39 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 180,000 | $86.65 | $15,597,720.00 |
DisclosureSEC source: 0001209191-18-038243 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,050,804 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $86.50 to $86.87, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| June 14, 2018 Filed Jun 15, 2018 15:00 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 107,698 | $86.31 | $9,295,414.38 |
DisclosureSEC source: 0001209191-18-037956 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,230,804 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $86.25 to $86.46, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| June 13, 2018 Filed Jun 14, 2018 15:58 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 11,104 | $86.27 | $957,953.18 |
DisclosureSEC source: 0001209191-18-037648 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,338,502 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $86.25 to $86.38, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| June 11, 2018 Filed Jun 12, 2018 18:46 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 51,198 | $86.38 | $4,422,636.83 |
DisclosureSEC source: 0001209191-18-037198 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,349,606 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $86.25 to $86.60, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| June 04, 2018 Filed Jun 5, 2018 15:20 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 135,478 | $85.13 | $11,532,564.75 |
DisclosureSEC source: 0001209191-18-035460 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,400,804 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.00 to $85.37, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| June 01, 2018 Filed Jun 4, 2018 18:25 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 39,522 | $85.31 | $3,371,661.34 |
DisclosureSEC source: 0001209191-18-034952 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,536,282 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.00 to $85.45, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| May 30, 2018 Filed May 31, 2018 17:18 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 180,000 | $83.85 | $15,092,640.00 |
DisclosureSEC source: 0001209191-18-034303 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,575,804 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.61 to $84.015, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| May 11, 2018 Filed May 14, 2018 18:29 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 140,000 | $81.97 | $11,475,940.00 |
DisclosureSEC source: 0001209191-18-029775 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,755,804 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.50 to $82.435, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| April 25, 2018 Filed Apr 26, 2018 16:38 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 1,100 | $81.57 | $89,728.10 |
DisclosureSEC source: 0001209191-18-026160 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,895,804 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.50 to $81.62, inclusive. Read SEC document |
| April 25, 2018 Filed Apr 26, 2018 16:38 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 178,900 | $80.85 | $14,463,886.10 |
DisclosureSEC source: 0001209191-18-026160 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,896,904 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.50 to $81.49, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| December 13, 2017 Filed Dec 14, 2017 16:26 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 8,300 | $88.89 | $737,753.80 |
DisclosureSEC source: 0001209191-17-065573 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,075,804 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $88.76 to $88.99, inclusive. Read SEC document |
| December 13, 2017 Filed Dec 14, 2017 16:26 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 191,700 | $88.17 | $16,901,422.20 |
DisclosureSEC source: 0001209191-17-065573 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,084,104 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.75 to $88.745, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| October 04, 2017 Filed Oct 5, 2017 18:56 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 205,000 | $86.81 | $17,795,025.00 |
DisclosureSEC source: 0001209191-17-056102 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,275,804 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $86.655 to $87.115, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| September 29, 2017 Filed Oct 2, 2017 19:39 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 32,443 | $85.50 | $2,773,714.29 |
DisclosureSEC source: 0001209191-17-054552 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,480,804 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.41 to $85.60, inclusive. Read SEC document |
| September 29, 2017 Filed Oct 2, 2017 19:39 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 162,557 | $85.07 | $13,828,886.55 |
DisclosureSEC source: 0001209191-17-054552 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,513,247 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.41 to $85.40, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| September 15, 2017 Filed Sep 18, 2017 19:42 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 6,483 | $83.32 | $540,170.04 |
DisclosureSEC source: 0001209191-17-053130 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,675,804 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.185 to $83.38, inclusive. Read SEC document |
| September 15, 2017 Filed Sep 18, 2017 19:42 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 183,517 | $82.50 | $15,139,601.95 |
DisclosureSEC source: 0001209191-17-053130 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,682,287 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.185 to $83.18, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| August 31, 2017 Filed Sep 1, 2017 17:45 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 180,000 | $81.06 | $14,590,080.00 |
DisclosureSEC source: 0001209191-17-051033 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,865,804 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.66 to $81.35, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| July 31, 2017 Filed Aug 1, 2017 14:55 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 3,479 | $83.68 | $291,129.68 |
DisclosureSEC source: 0001209191-17-046854 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,045,804 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.65 to $83.75, inclusive. Read SEC document |
| July 31, 2017 Filed Aug 1, 2017 14:55 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 216,521 | $83.08 | $17,988,348.16 |
DisclosureSEC source: 0001209191-17-046854 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,049,283 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.65 to $83.64, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| June 22, 2017 Filed Jun 23, 2017 14:16 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 210,000 | $84.43 | $17,730,720.00 |
DisclosureSEC source: 0001209191-17-041545 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,265,804 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.78 to $84.76, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| June 20, 2017 Filed Jun 21, 2017 15:24 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 215,000 | $83.05 | $17,855,363.00 |
DisclosureSEC source: 0001209191-17-041164 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,475,804 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.66 to $83.655, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| March 30, 2017 Filed Mar 31, 2017 15:11 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 210,000 | $84.67 | $17,781,540.00 |
DisclosureSEC source: 0001209191-17-023790 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,690,804 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.51 to $84.95, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| February 27, 2017 Filed Feb 28, 2017 18:21 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 225,000 | $83.06 | $18,688,950.00 |
DisclosureSEC source: 0001209191-17-015113 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,900,804 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.68 to $83.38, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| February 17, 2017 Filed Feb 21, 2017 20:45 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 230,000 | $80.27 | $18,462,790.00 |
DisclosureSEC source: 0001209191-17-012604 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,125,804 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.09 to $80.56, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| February 01, 2017 Filed Feb 2, 2017 20:38 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 3,243 | $78.04 | $253,070.75 |
DisclosureSEC source: 0001209191-17-007037 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,355,804 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.00 to $78.12, inclusive. Read SEC document |
| February 01, 2017 Filed Feb 2, 2017 20:38 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 216,757 | $77.34 | $16,763,769.62 |
DisclosureSEC source: 0001209191-17-007037 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,359,047 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.00 to $77.99, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| December 16, 2016 Filed Dec 19, 2016 22:02 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 73,604 | $73.07 | $5,378,023.47 |
DisclosureSEC source: 0001209191-16-155956 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,575,804 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.83 to $73.35, inclusive. Read SEC document |
| December 16, 2016 Filed Dec 19, 2016 22:02 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 126,396 | $72.32 | $9,140,453.14 |
DisclosureSEC source: 0001209191-16-155956 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,649,408 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.83 to $72.825, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price withing the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| July 29, 2016 Filed Aug 1, 2016 17:29 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 205,000 | $82.94 | $17,001,880.00 |
DisclosureSEC source: 0001209191-16-134556 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,775,804 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.66 to $83.15, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| July 28, 2016 Filed Jul 29, 2016 17:57 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 39,766 | $83.13 | $3,305,588.52 |
DisclosureSEC source: 0001209191-16-134407 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,980,804 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.07 to $83.19, inclusive. Read SEC document |
| July 28, 2016 Filed Jul 29, 2016 17:57 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 200,234 | $82.82 | $16,582,979.41 |
DisclosureSEC source: 0001209191-16-134407 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,020,570 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.07 to $83.06, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| July 12, 2016 Filed Jul 13, 2016 14:49 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 210,000 | $79.54 | $16,703,820.00 |
DisclosureSEC source: 0001209191-16-132483 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,220,804 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.285 to $79.83, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| July 07, 2016 Filed Jul 8, 2016 17:06 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 11,705 | $79.71 | $933,017.26 |
DisclosureSEC source: 0001209191-16-132119 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,430,804 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.65 to $79.76, inclusive. Read SEC document |
| July 07, 2016 Filed Jul 8, 2016 17:06 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 213,295 | $79.11 | $16,873,340.86 |
DisclosureSEC source: 0001209191-16-132119 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,442,509 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.65 to $79.64, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| June 30, 2016 Filed Jul 1, 2016 15:36 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 152,900 | $78.60 | $12,017,634.20 |
DisclosureSEC source: 0001209191-16-130365 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,655,804 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.49 to $78.805, inclusive. Read SEC document |
| June 30, 2016 Filed Jul 1, 2016 15:36 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 62,100 | $78.14 | $4,852,307.70 |
DisclosureSEC source: 0001209191-16-130365 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,808,704 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.49 to $78.485, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| June 29, 2016 Filed Jun 30, 2016 19:14 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 92,981 | $78.09 | $7,260,421.39 |
DisclosureSEC source: 0001209191-16-130204 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,870,804 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.96 to $78.24, inclusive. Read SEC document |
| June 29, 2016 Filed Jun 30, 2016 19:14 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 127,019 | $77.70 | $9,868,741.21 |
DisclosureSEC source: 0001209191-16-130204 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,963,785 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.96 to $77.955, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| May 31, 2016 Filed Jun 1, 2016 18:49 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 200,000 | $75.12 | $15,023,200.00 |
DisclosureSEC source: 0001209191-16-124593 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,090,804 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $74.72 to $75.50, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| May 12, 2016 Filed May 13, 2016 19:09 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 5,106 | $76.60 | $391,119.60 |
DisclosureSEC source: 0001209191-16-119838 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,290,804 F2 · price: The price reported in Column 4 is a weighted average price of $76.600. These shares were sold in multiple transactions at prices ranging from $76.41 to $76.67, inclusive. Read SEC document |
| May 12, 2016 Filed May 13, 2016 19:09 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 184,894 | $75.84 | $14,022,915.64 |
DisclosureSEC source: 0001209191-16-119838 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,295,910 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.36 to $76.30, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| April 29, 2016 Filed May 2, 2016 20:00 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 201 | $76.10 | $15,296.10 |
DisclosureSEC source: 0001209191-16-116721 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,480,804 F2 · price: The price reported in Column 4 is a weighted average price of $76.100. These shares were sold in multiple transactions at prices ranging from $76.10 to $76.11, inclusive. Read SEC document |
| April 29, 2016 Filed May 2, 2016 20:00 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 179,799 | $75.44 | $13,564,755.76 |
DisclosureSEC source: 0001209191-16-116721 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,481,005 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.10 to $76.09, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| April 08, 2016 Filed Apr 11, 2016 19:07 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 200,000 | $74.29 | $14,857,800.00 |
DisclosureSEC source: 0001209191-16-113848 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,660,804 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $73.89 to $74.73, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.